Edition:
India

Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

33.18CAD
22 Mar 2019
Change (% chg)

$-0.84 (-2.47%)
Prev Close
$34.02
Open
$33.88
Day's High
$33.91
Day's Low
$32.75
Volume
962,965
Avg. Vol
1,056,047
52-wk High
$36.52
52-wk Low
$19.36

Chart for

About

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $5,024.01
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  BHC.TO Industry Sector
P/E (TTM): -- 29.30 32.54
EPS (TTM): -3.27 -- --
ROI: -2.83 14.23 13.82
ROE: -24.78 15.46 15.24

UPDATE 1-Ex-Valeant, Philidor executives get prison for fraud

NEW YORK, Oct 30 A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme.

31 Oct 2018

Ex-Valeant, Philidor executives get prison for fraud

NEW YORK, Oct 30 A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme.

30 Oct 2018

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Bausch Health Cos Inc, formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali.

08 Oct 2018

UPDATE 2-Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Oct 8 Bausch Health Cos Inc , formerly Valeant Pharmaceuticals, said on Monday it received tentative U.S. approval to market its plaque psoriasis lotion, Bryhali.

08 Oct 2018

Bausch Health's plaque psoriasis lotion gets tentative FDA approval

Oct 8 Bausch Health Cos said on Monday it received tentative approval from the U.S. health regulator to market its plaque psoriasis lotion, Bryhali.

08 Oct 2018

Bausch Health unit moves to settle charges it misled investors -SEC

WASHINGTON Salix Pharmaceuticals, a unit of Bausch Health Companies Inc , has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

28 Sep 2018

UPDATE 3-Bausch Health unit moves to settle charges it misled investors -SEC

WASHINGTON, Sept 28 Salix Pharmaceuticals, a unit of Bausch Health Companies Inc, has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

28 Sep 2018

Bausch Health subsidiary moves to settle charges it misled investors -SEC

WASHINGTON, Sept 28 Salix Pharmaceuticals, a unit of Bausch Health Companies Inc, has moved to settle charges brought by the U.S. Securities and Exchange Commission that it misled investors about the company's prospects, the SEC said on Friday.

28 Sep 2018

Earnings vs. Estimates